Market Overview American pharmaceutical policy increasingly emphasizes domestic active pharmaceutical ingredient manufacturing as a matter of national health security and industrial competitiveness. Atorvastatin API production, historically concentrated in Asian chemical manufacturing hubs, is attracting renewed American investment driven by federal reshoring incentives, pandemic supply chain...